It has been yet another busy medical day in our ‘new-normal’ coronavirus world. Today, the Phase One results of the University of Oxford vaccine were published, confirming positive reports tantalisingly leaked last week. Also making the news is a press release from the pharmaceutical company Synairgen, touting very positive initial results from its inhaled protein, interferon-beta, in treating hospitalised patients with coronavirus.
Already a subscriber? Log in
As the US decides, so can you
Subscribe today and get a $50 Amazon gift card if you correctly predict the next US president.
- Unlimited access to spectator.com.au
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
As the US decides, so can you
Subscribe today and get a $50 Amazon gift card if you correctly predict the next US president.
SUBSCRIBE AND ENTERAlready a subscriber? Log in